The combination of topical ceftazidime and aminoglycosides in the treatment of refractory pseudomonal keratitis
暂无分享,去创建一个
[1] G. Holland,et al. Combination intravenous ceftazidime and aminoglycosides in the treatment of pseudomonal scleritis. , 1997, Ophthalmology.
[2] F. Colardyn. The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection. , 1995, Journal of chemotherapy.
[3] D. Gaton,et al. The Effect of Topical Ceftazidime on Pseudomonas Keratitis in Rabbits , 1994, Cornea.
[4] M. Papapetropoulou,et al. Occurrence and antibiotic-resistance of Pseudomonas species isolated from drinking water in southern Greece. , 1994, Journal of chemotherapy.
[5] H. Leibowitz. Clinical evaluation of ciprofloxacin 0.3% ophthalmic solution for treatment of bacterial keratitis. , 1991, American journal of ophthalmology.
[6] G. Baerveldt,et al. GENTAMICIN‐RESISTANT PSEUDOMONAL INFECTION: RATIONALE FOR A REDEFINITION OF OPHTHALMIC ANTIMICROBIAL SENSITIVITIES , 1989, Cornea.
[7] R. J. Mack,et al. An in vitro analysis of aminoglycoside corneal epithelial toxicity. , 1989, Current eye research.
[8] C. Foster,et al. Microbial keratitis complicating penetrating keratoplasty. , 1988, Ophthalmology.
[9] R. Wise. ANTIMICROBIAL AGENTS: A WIDENING CHOICE , 1987, The Lancet.
[10] G. Eliopoulos,et al. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms. , 1986, The American journal of medicine.
[11] J. Blaser,et al. Impact of netilmicin regimens on the activities of ceftazidime-netilmicin combinations against Pseudomonas aeruginosa in an in vitro pharmacokinetic model , 1985, Antimicrobial Agents and Chemotherapy.
[12] A. J. Godfrey,et al. Virulence of Pseudomonas aeruginosa strains with mechanisms of microbial persistence for beta-lactam and aminoglycoside antibiotics in a mouse infection model. , 1985, Canadian journal of microbiology.
[13] K. Berndt,et al. Effect of highly potent antipseudomonal beta-lactam agents alone and in combination with aminoglycosides against Pseudomonas aeruginosa. , 1984, Reviews of infectious diseases.
[14] E J Cohen,et al. Corneal ulcers associated with contact lens wear. , 1984, Archives of ophthalmology.
[15] B A Weissman,et al. Corneal ulcers associated with extended-wear soft contact lenses. , 1984, American journal of ophthalmology.
[16] H. Gelender,et al. Gentamicin‐Resistant Pseudomonas aeruginosa Corneal Ulcers* , 1984, Cornea.
[17] G. Stern,et al. Effect of topical antibiotic solutions on corneal epithelial wound healing. , 1983, Archives of ophthalmology.
[18] M. Marks,et al. Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis , 1982, Antimicrobial Agents and Chemotherapy.
[19] P. Laibson,et al. A clinical comparison of tobramycin and gentamicin sulfate in the treatment of ocular infections. , 1981, American journal of ophthalmology.
[20] L. Wilson,et al. Pseudomonas corneal ulcers associated with soft contact-lens wear. , 1981, American journal of ophthalmology.
[21] A. Brucker,et al. Experimental pseudomonal posttraumatic endophthalmitis in a swine model. Treatment with ceftazidime, amikacin, and imipenem. , 1997, Retina.
[22] R. Smith,et al. Comparative antimicrobial activity of FK037, cefpirome, ceftazidime and cefepime against aminoglycoside-sensitive and aminoglycoside-resistant Pseudomonas aeruginosa and Pseudomonas spp. , 1994, Chemotherapy.
[23] H. Flynn,et al. Intraocular ceftazidime as an alternative to the aminoglycosides in the treatment of endophthalmitis. , 1994, Archives of ophthalmology.
[24] D. Seal,et al. Pathogenesis and therapy of pseudomonas aeruginosa keratitis , 1988, Eye.
[25] J. Marks,et al. [Ulcers]. , 1986, Phlebologie.
[26] N. Høiby,et al. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin. , 1983, Scandinavian journal of infectious diseases.